BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high‐risk pancreatic cancer screening and pancreatic cancer cohorts

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|120|13|1960-1967

ISSN: 0008-543x

Source: CANCER, Vol.120, Iss.13, 2014-07, pp. : 1960-1967

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract